There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.
Anna Lee Petit, Kaitlin Kennedy, David Ellison, PharmD Candidates 2021 Auburn University Harrison School of Pharmacy
Advertisement
Articles by Anna Lee Petit, Kaitlin Kennedy, David Ellison, PharmD Candidates 2021 Auburn University Harrison School of Pharmacy
Advertisement
Latest Updated Articles
Monoclonal Antibodies Show Promise Treating COVID-19January 12th 2021
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
4
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
5